3SBIO INC. (Stock Code: 1530.HK), is a fully integrated, profitable bio-pharmaceutical company focused on discovering, researching, developing, manufacturing and commercializing bio-pharmaceutical products in the global market. We are the forerunner and incontrovertible leader of Chinese bio-pharmaceutical industry.
We have five major production bases in the world, located in: Shenyang, Shanghai, Shenzhen, Hangzhou and Italy. Our diversified products cover various therapeutic fields, such as oncology, autoimmune diseases, nephrology, metabolic disease and are in the market leading position and have strong growth momentum and huge growth potential.
We are continually devote ourselves to our global business expansion. We have been conducting a International Multi-center Clinical Trial for EPIAO in Russia and Thailand.
Our product groups：
Recombinant Human Erythropoietin Injection (EPIAO), Recombinant Human Thrombopoietin Injection (TPIAO),Recombinant Human Type II Tumor Necrosis Factor Receptor - Antibody Fusion Protein Injection (YISAIPU)